Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 9, Pages 2001
Publisher
MDPI AG
Online
2021-04-22
DOI
10.3390/cancers13092001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Explainable COVID-19 Detection Using Chest CT Scans and Deep Learning
- (2021) Hammam Alshazly et al. SENSORS
- Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial
- (2021) Ashley M. Hopkins et al. Cancers
- Development and validation of a prognostic model for patients with advanced lung cancer treated with the immune checkpoint inhibitor atezolizumab
- (2020) Ashley M Hopkins et al. CLINICAL CANCER RESEARCH
- A literature review of treatment-specific clinical prediction models in patients with breast cancer
- (2020) Natansh D. Modi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Automated detection of COVID-19 cases using deep neural networks with X-ray images
- (2020) Tulin Ozturk et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
- (2020) Guru Sonpavde et al. JOURNAL OF UROLOGY
- Machine Learning for Survival Analysis
- (2019) Ping Wang et al. ACM COMPUTING SURVEYS
- Evaluation of the lung immune prognostic index for prediction of survival and response in patients treated with atezolizumab for non-small cell lung cancer: pooled analysis of clinical trials.
- (2019) Michael J. Sorich et al. Journal of Thoracic Oncology
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
- (2018) Thomas Powles et al. LANCET
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- FRANK E. HARRELL, Jr., Regression Modeling Strategies: With Applications, to Linear Models, Logistic and Ordinal Regression, and Survival Analysis, 2nd ed. Heidelberg: Springer.
- (2016) E. W. Steyerberg BIOMETRICS
- Small data sets to develop and validate prognostic models are problematic
- (2016) Gary S. Collins et al. EUROPEAN JOURNAL OF CANCER
- Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma
- (2016) Guru Sonpavde et al. JOURNAL OF UROLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Refining Prognosis in Lung Cancer
- (2015) Alyson L. Mahar et al. Journal of Thoracic Oncology
- Machine learning applications in cancer prognosis and prediction
- (2015) Konstantina Kourou et al. Computational and Structural Biotechnology Journal
- Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens
- (2010) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now